14-HEM-05-SA (TED12414) Extension study for patients benefiting from treatment on ARD12130

Grants and Contracts Details

StatusFinished
Effective start/end date1/1/1410/31/14

Funding

  • Sanofi Aventis US Inc: $9,122.00